Mary A Tagliaferri
4PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 05, 2024
Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09).Nizar M Tannir, Maria Nirvana Formiga, Konstantin Penkov
|Aug 31, 2023
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results.Adi Diab, Helen Gogas, Shahneen Sandhu
|Jul 13, 2021
Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma.Adi Diab, Scott S Tykodi, Gregory A Daniels
|Jun 22, 2021
Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies.Nina Shah, Miguel-Angel Perales, Cameron J Turtle
Pageof 1
Frequent Collaborators
2 joint publications
Adi Diab
1 joint publications
Nina Shah
1 joint publications
Miguel-Angel Perales
1 joint publications
Cameron J Turtle
1 joint publications
Mitchell S Cairo
1 joint publications
Andrew J Cowan
1 joint publications
Hayder Saeed
1 joint publications
Lihua E Budde
1 joint publications
Jonathan Zalevsky
1 joint publications
Gregory A Daniels
